Jeffrey M. Drazen, MD
NEJM Group Editor
In 2000, Dr. Drazen was named Editor-in-Chief of the New England Journal of Medicine. Under his leadership, NEJM published major papers advancing the science of medicine, including the first descriptions of SARS, timely coverage of the Ebola and Zika virus epidemics, and advances in the treatment of cancer, heart disease and lung disease. During his tenure, NEJM was at the forefront of worldwide efforts to register all clinical trials and to share clinical trial data. In September 2019, Dr. Drazen retired from his role as Editor-in-Chief. He now serves as NEJM Group Editor.